Search
Mostrar filtros
Add filters:
Use filters to refine the search results.
Results 1-10 of 17 (Search time: 0.004 seconds).
| Issue Date | Title | Author(s) |
|---|---|---|
| 2012 | Metronomic chemotherapy (MC): Results of two feasibility trials in patients (pts) with HER2 positive (HER2+) and negative (HER2-) locally advanced breast cancer (LABC) | PETRY, Vanessa; LEAL, Alessandro; ARAI, Roberto J.; PIATO, Jose R.; ANDRADE, Felipe; PAIVA, Marcelo; FERRAZ, Marcio R.; MARINHO, Simone; HOFF, Paulo Marcelo; MANO, Max S. |
| 2012 | Excision repair cross-complementary group 1 (ERCC1) as a prognostic biomarker in patients (pts) with solid tumors: A meta-analysis on detection methods | MAK, Milena Perez; TAKAHASHI, Tiago Kenji; HOFF, Paulo Marcelo; CASTRO, Gilberto; SNITCOVSKY, Igor M. L. |
| 2012 | Expression of ERCC1 protein (excision repair cross complementing group 1) in patients with invasive carcinoma of the uterine cervix (CC) undergoing definitive chemoradiation (CR) | CAIRES, Inacelli Queiroz de Souza; CAIRES-LIMA, Rafael; COLOMBO, Renata; RAMOS, Clarissa C. A.; MACHADO, Karime Kalil; SIQUEIRA, Sheila Aparecida Coelho; CARVALHO, Heloisa de Andrade; FUKUSHIMA, Julia Tizue; ADRA, Thais Rodrigues; HOFF, Paulo M.; ESTEVEZ-DIZ, Maria Del Pilar |
| 2012 | Self-reported conflicts of interest (sfCOI) of authors and the interpretation of randomized phase III trials (RCT) and related editorials (REd) in cancer research | BARIANI, Giovanni Mendonca; FERRARI, Anezka Carvalho Rubin De Celis; HOFF, Paulo Marcelo; RIECHELMANN, Rachel |
| 2012 | A randomized, open-label, phase II study of lapatinib/capecitabine, lapatinib/vinorelbine, or lapatinib/gemcitabine in patients with ErbB2-amplified metastatic breast cancer progressing after taxane treatment: Results of an interim analysis (GLICO-0801/EGF111792) | GOMEZ, Henry Leonidas; NECIOSUP, Silvia P.; TOSELLO, Celia; XAVIER, Patricia; NASCIMENTO, Yeni Neron do; FANELLI, Marcelo; ISMAEL, Gustavo; BINES, Jose; SAMPAIO, Carlos; LERZO, Guillermo Luis; CAPO, Adolfo Miguel; MANO, Max S.; FEIN, Luis; WERUTSKY, Gustavo; BARRIOS, Carlos H. |
| 2012 | Discordance between Oncotype Dx and Saint Gallen criteria, Adjuvant!, NCCN 2011 guidelines, and initial physician treatment recommendation | PEREIRA, Allan Andresson Lima; SANTINI, Fernando Costa; SHIMADA, Andrea Kazumi; NASCIMENTO, Ellen Caroline; KATZ, Artur; MANO, Max S. |
| 2012 | A randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: The LARCID trial. | HOFF, Paulo Marcelo; SARAGIOTTO, Daniel Fernandes; BARRIOS, Carlos H.; GIGLIO, Auro Del; COUTINHO, Anelisa Kruschewsky; ANDRADE, Aline C.; DUTRA, Carolina; FORONES, Nora; CORREA, Mariangela; PORTELLA, Maria Socorro; PASSOS, Vanessa Q.; CHINEN, Renata N.; EYLL, Brigitte van |
| 2012 | Use of bevacizumab to reduce the rate of oxaliplatin-induced thrombocytopenia and splenomegaly. | OVERMAN, Michael J.; GEORGE, Binsah; KALIL, Karime; FERRAROTTO, Renata; ENG, Cathy; GARRETT, Chris R.; LOYER, Evelyn; HOFF, Paulo Marcelo; CHARNSANGAVEJ, Chusilp; KOPETZ, Scott |
| 2012 | Percutaneous transhepatic biliary drainage (PTBD) in patients (pts) with advanced solid malignancies: Clinical outcomes and prognostic factors | CROSARA, Marcela Alves Teixeira; MAK, Milena P.; MARQUES, Daniel Fernandes; CAPARELI-AZEVEDO, Fernanda C.; HOFF, Paulo Marcelo |
| 2012 | Phase II study of capecitabine in substitution of 5-FU in the chemoradiotherapy regimen for patients with squamous cell carcinoma of the anal canal. | RIBEIRO, Suilane Coelho; VENCHIARUTTI, Camila; RIECHELMANN, Rachel; GIL, Erlon; NAHAS, Caio; COUDRY, Renata; FREITAS, Daniela; SARAGIOTTO, Daniel F.; ARRUDA, Fernando; AZAMBUJA, Rodrigo; HOFF, Paulo |